Waluga M - Search Results

1

Insulin resistance and its consequences in chronic hepatitis C.

Kukla M, Piotrowski D, Waluga M, Hartleb M. Kukla M, et al. Among authors: waluga m. Clin Exp Hepatol. 2015 May;1(1):17-29. doi: 10.5114/ceh.2015.51375. Epub 2015 Apr 30. Clin Exp Hepatol. 2015. PMID: 28856251 Free PMC article. Review.

2

The theophylline disposition after caffeine administration in liver cirrhosis: an index of liver function.

Hartleb M, Romańczyk T, Becker A, Mańczyk I, Waluga M, Spalińska M, Zieliński M. Hartleb M, et al. Among authors: waluga m. Ital J Gastroenterol. 1992 Jul-Aug;24(6):332-7. Ital J Gastroenterol. 1992. PMID: 1515659

3

Cardiovascular status after postural change in compensated cirrhosis: an argument for vasodilatory concept.

Hartleb M, Rudzki K, Karpel E, Becker A, Waluga M, Boldys H, Nowak A, Nowak S. Hartleb M, et al. Among authors: waluga m. Liver. 1997 Feb;17(1):1-6. doi: 10.1111/j.1600-0676.1997.tb00770.x. Liver. 1997. PMID: 9062872

4

Cardiovascular changes after treatment with dexfenfluramine and yohimbine in obese women measured by thoracic electrical bioimpedance.

Waluga M, Janusz M, Karpel E, Hartleb M, Nowak A. Waluga M, et al. Boll Chim Farm. 1999 Jul-Aug;138(7):359-63. Boll Chim Farm. 1999. PMID: 10597657 Clinical Trial.

5

Usefulness of thoracic electrical bioimpedance in detection of ejection fraction changes.

Hartleb M, Rudzki K, Waluga M, Janusz M, Karpel E. Hartleb M, et al. Among authors: waluga m. J Physiol Pharmacol. 2000 Mar;51(1):151-9. J Physiol Pharmacol. 2000. PMID: 10768858 Free article.

6

[Alcoholic liver disease].

Waluga M, Hartleb M. Waluga M, et al. Wiad Lek. 2003;56(1-2):61-70. Wiad Lek. 2003. PMID: 12901271 Review. Polish.

7

Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies.

Hartleb M, Wandzel P, Waluga M, Matyszczyk B, Bołdys H, Romañczyk T. Hartleb M, et al. Among authors: waluga m. Acta Gastroenterol Belg. 2004 Oct-Dec;67(4):320-6. Acta Gastroenterol Belg. 2004. PMID: 15727075

8

Visfatin serum levels in chronic hepatitis C patients.

Kukla M, Zwirska-Korczala K, Gabriel A, Waluga M, Warakomska I, Berdowska A, Rybus-Kalinowska B, Kalinowski M, Janczewska-Kazek E, Woźniak-Grygiel E, Kryczka W. Kukla M, et al. Among authors: waluga m. J Viral Hepat. 2010 Apr;17(4):254-60. doi: 10.1111/j.1365-2893.2009.01174.x. Epub 2009 Oct 13. J Viral Hepat. 2010. PMID: 19840367

9

Chemerin, vaspin and insulin resistance in chronic hepatitis C.

Kukla M, Zwirska-Korczala K, Gabriel A, Waluga M, Warakomska I, Szczygiel B, Berdowska A, Mazur W, Wozniak-Grygiel E, Kryczka W. Kukla M, et al. Among authors: waluga m. J Viral Hepat. 2010 Sep;17(9):661-7. doi: 10.1111/j.1365-2893.2009.01224.x. Epub 2009 Nov 11. J Viral Hepat. 2010. PMID: 20002564

10

Serum chemerin and vaspin in non-alcoholic fatty liver disease.

Kukla M, Zwirska-Korczala K, Hartleb M, Waluga M, Chwist A, Kajor M, Ciupinska-Kajor M, Berdowska A, Wozniak-Grygiel E, Buldak R. Kukla M, et al. Among authors: waluga m. Scand J Gastroenterol. 2010;45(2):235-42. doi: 10.3109/00365520903443852. Scand J Gastroenterol. 2010. PMID: 20095887

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page